Raras
Buscar doenças, sintomas, genes...
Doença do desenvolvimento sexual 46,XY
ORPHA:98085DOENÇA RARA

Diferenças do Desenvolvimento Sexual em pessoas com o conjunto de cromossomos 46,XY.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Diferenças do Desenvolvimento Sexual em pessoas com o conjunto de cromossomos 46,XY.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.06
Denmark
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
34 sintomas
🧠
Neurológico
34 sintomas
😀
Face
33 sintomas
📏
Crescimento
31 sintomas
🫘
Rins
27 sintomas
❤️
Coração
22 sintomas

+ 228 sintomas em outras categorias

Características mais comuns

Polegar largo
Hemorragia retal
Testículo ausente
Fístula uretrovaginal
Genitália externa ausente
Hemoglobina anormal
495sintomas
Sem dados (495)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 495 características clínicas mais associadas, ordenadas por frequência.

Polegar largoBroad thumb
Hemorragia retalHP:6001316
Testículo ausenteAbsent testis
Fístula uretrovaginalUrethrovaginal fistula
Genitália externa ausenteAbsent external genitalia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa9
Últimos 10 anos200publicações
Pico202234 papers
Linha do tempo
20202017Hoje · 2026🧪 2009Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

24 genes identificados com associação a esta condição.

SRD5A23-oxo-5-alpha-steroid 4-dehydrogenase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Converts testosterone (T) into 5-alpha-dihydrotestosterone (DHT) and progesterone or corticosterone into their corresponding 5-alpha-3-oxosteroids. It plays a central role in sexual differentiation and androgen physiology

LOCALIZAÇÃO

Microsome membraneEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Androgen biosynthesis
MECANISMO DE DOENÇA

Pseudovaginal perineoscrotal hypospadias

A form of male pseudohermaphroditism in which 46,XY males show ambiguous genitalia at birth, including perineal hypospadias and a blind perineal pouch, and develop masculinization at puberty. The name of the disorder stems from the finding of a blind-ending perineal opening resembling a vagina and a severely hypospadiac penis with the urethra opening onto the perineum.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Próstata
25.8 TPM
Fígado
11.2 TPM
Testículo
3.7 TPM
Vagina
2.3 TPM
Cervix Endocervix
0.7 TPM
OUTRAS DOENÇAS (2)
46,XY disorder of sex development due to 5-alpha-reductase 2 deficiencyprostate cancer, hereditary
HGNC:11285UniProt:P31213
DHX37Probable ATP-dependent RNA helicase DHX37Candidate gene tested inAltamente restrito
FUNÇÃO

ATP-binding RNA helicase that plays a role in maturation of the small ribosomal subunit in ribosome biogenesis (PubMed:30582406). Required for the release of the U3 snoRNP from pre-ribosomal particles (PubMed:30582406). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and wor

LOCALIZAÇÃO

Nucleus, nucleolusCytoplasmNucleus membrane

VIAS BIOLÓGICAS (2)
rRNA modification in the nucleus and cytosolMajor pathway of rRNA processing in the nucleolus and cytosol
MECANISMO DE DOENÇA

Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies

An autosomal recessive neurodevelopmental disorder characterized by severe developmental delay, impaired intellectual development, hypotonia, brain anomalies including cortical volume loss, corpus callosum dysgenesis and cerebellar hypoplasia, and variable dysmorphic features. Patients may have platyspondyly, scoliosis, and cardiac anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
34.9 TPM
Fibroblastos
19.3 TPM
Ovário
19.0 TPM
Útero
18.1 TPM
Nervo tibial
17.0 TPM
OUTRAS DOENÇAS (4)
neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies46,XY sex reversal 1146,XY complete gonadal dysgenesis46,XY partial gonadal dysgenesis
HGNC:17210UniProt:Q8IY37
WWOXWW domain-containing oxidoreductaseCandidate gene tested inTolerante
FUNÇÃO

Putative oxidoreductase. Acts as a tumor suppressor and plays a role in apoptosis. Required for normal bone development (By similarity). May function synergistically with p53/TP53 to control genotoxic stress-induced cell death. Plays a role in TGFB1 signaling and TGFB1-mediated cell death. May also play a role in tumor necrosis factor (TNF)-mediated cell death. Inhibits Wnt signaling, probably by sequestering DVL2 in the cytoplasm

LOCALIZAÇÃO

CytoplasmNucleusMitochondrionGolgi apparatusLysosome

VIAS BIOLÓGICAS (3)
Nuclear signaling by ERBB4Activation of the TFAP2 (AP-2) family of transcription factorsNegative regulation of activity of TFAP2 (AP-2) family transcription factors
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
13.8 TPM
Cérebro - Hemisfério cerebelar
12.1 TPM
Cerebelo
11.2 TPM
Brain Spinal cord cervical c-1
10.5 TPM
Nervo tibial
8.2 TPM
OUTRAS DOENÇAS (5)
autosomal recessive spinocerebellar ataxia 12esophageal cancerdevelopmental and epileptic encephalopathy, 28esophageal squamous cell carcinoma
HGNC:12799UniProt:Q9NZC7
VAMP7Vesicle-associated membrane protein 7Candidate gene tested inTolerante
FUNÇÃO

Involved in the targeting and/or fusion of transport vesicles to their target membrane during transport of proteins from the early endosome to the lysosome. Required for heterotypic fusion of late endosomes with lysosomes and homotypic lysosomal fusion. Required for calcium regulated lysosomal exocytosis. Involved in the export of chylomicrons from the endoplasmic reticulum to the cis Golgi. Required for exocytosis of mediators during eosinophil and neutrophil degranulation, and target cell kill

LOCALIZAÇÃO

Cytoplasmic vesicle, secretory vesicle membraneGolgi apparatus, trans-Golgi network membraneLate endosome membraneLysosome membraneEndoplasmic reticulum membraneCytoplasmic vesicle, phagosome membraneSynapse, synaptosome

VIAS BIOLÓGICAS (1)
Clathrin-mediated endocytosis
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
55.1 TPM
Linfócitos
52.2 TPM
Fibroblastos
50.7 TPM
Aorta
50.7 TPM
Artéria coronária
47.1 TPM
OUTRAS DOENÇAS (1)
46,XY partial gonadal dysgenesis
HGNC:11486UniProt:P51809
MTM1MyotubularinCandidate gene tested inAltamente restrito
FUNÇÃO

Lipid phosphatase which dephosphorylates phosphatidylinositol 3-monophosphate (PI3P) and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) (PubMed:10900271, PubMed:11001925, PubMed:12646134, PubMed:14722070). Has also been shown to dephosphorylate phosphotyrosine- and phosphoserine-containing peptides (PubMed:9537414). Negatively regulates EGFR degradation through regulation of EGFR trafficking from the late endosome to the lysosome (PubMed:14722070). Plays a role in vacuolar formation and morph

LOCALIZAÇÃO

CytoplasmCell membraneCell projection, filopodiumCell projection, ruffleLate endosomeCytoplasm, myofibril, sarcomere

VIAS BIOLÓGICAS (3)
Synthesis of PIPs at the plasma membraneSynthesis of PIPs at the early endosome membraneSynthesis of PIPs at the late endosome membrane
MECANISMO DE DOENÇA

Myopathy, centronuclear, X-linked

A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
18.1 TPM
Nervo tibial
17.3 TPM
Ovário
17.1 TPM
Baço
14.4 TPM
Glândula adrenal
14.4 TPM
OUTRAS DOENÇAS (3)
X-linked myotubular myopathycentronuclear myopathyX-linked myotubular myopathy-abnormal genitalia syndrome
HGNC:7448UniProt:Q13496
SRYSex-determining region Y proteinCandidate gene tested inDesconhecido
FUNÇÃO

Transcriptional regulator that controls a genetic switch in male development (PubMed:11563911). It is necessary and sufficient for initiating male sex determination by directing the development of supporting cell precursors (pre-Sertoli cells) as Sertoli rather than granulosa cells (PubMed:16414182, PubMed:16996051). Involved in different aspects of gene regulation including promoter activation or repression (PubMed:9525897). Binds to the DNA consensus sequence 5'-[AT]AACAA[AT]-3' (PubMed:115639

LOCALIZAÇÃO

Nucleus speckleCytoplasmNucleus

VIAS BIOLÓGICAS (2)
Deactivation of the beta-catenin transactivating complexTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

46,XY sex reversal 1

A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype. Patients manifest rapid and early degeneration of their gonads, which are present in the adult as 'streak gonads', consisting mainly of fibrous tissue and variable amounts of ovarian stroma. As a result these patients do not develop secondary sexual characteristics at puberty. The external genitalia in these subjects are completely female, and Muellerian structures are normal.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
4.5 TPM
Skin Sun Exposed Lower leg
3.4 TPM
Skin Not Sun Exposed Suprapubic
3.1 TPM
Fibroblastos
1.6 TPM
Esôfago - Mucosa
0.8 TPM
OUTRAS DOENÇAS (6)
46,XY sex reversal 145,X/46,XY mixed gonadal dysgenesis46,XY complete gonadal dysgenesis46,XX ovotesticular disorder of sex development
HGNC:11311UniProt:Q05066
MAMLD1Mastermind-like domain-containing protein 1Candidate gene tested inAltamente restrito
FUNÇÃO

Transactivates the HES3 promoter independently of NOTCH proteins. HES3 is a non-canonical NOTCH target gene which lacks binding sites for RBPJ

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (10)
NOTCH1 Intracellular Domain Regulates TranscriptionPre-NOTCH Transcription and TranslationNOTCH4 Intracellular Domain Regulates TranscriptionNOTCH3 Intracellular Domain Regulates TranscriptionRegulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
MECANISMO DE DOENÇA

Hypospadias 2, X-linked

A common malformation in which the urethra opens on the ventral side of the penis, due to developmental arrest of urethral fusion. The opening can be located glandular, penile, or even more posterior in the scrotum or perineum. Hypospadias is a feature of several syndromic disorders, including the androgen insensitivity syndrome and Opitz syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
36.4 TPM
Ovário
33.9 TPM
Nervo tibial
24.9 TPM
Cervix Endocervix
17.0 TPM
Fallopian Tube
16.5 TPM
OUTRAS DOENÇAS (3)
hypospadias 2, X-linkedX-linked myotubular myopathy-abnormal genitalia syndromeposterior hypospadias
HGNC:2568UniProt:Q13495
BDNFNeurotrophic factor BDNF precursor formCandidate gene tested inAltamente restrito
FUNÇÃO

Important signaling molecule that activates signaling cascades downstream of NTRK2 (PubMed:11152678). During development, promotes the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems. Participates in axonal growth, pathfinding and in the modulation of dendritic growth and morphology. Major regulator of synaptic transmission and plasticity at adult synapses in many regions of the CNS. The versatility of BDNF is emphasized by its contribu

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (10)
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingPIP3 activates AKT signalingConstitutive Signaling by Aberrant PI3K in CancerActivated NTRK2 signals through PI3KActivated NTRK2 signals through PLCG1
OUTRAS DOENÇAS (2)
WAGR syndromecentral hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease
HGNC:1033UniProt:P23560
PPP2R3CSerine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gammaCandidate gene tested inTolerante
FUNÇÃO

May regulate MCM3AP phosphorylation through phosphatase recruitment (By similarity). May act as a negative regulator of ABCB1 expression and function through the dephosphorylation of ABCB1 by TFPI2/PPP2R3C complex (PubMed:24333728). May play a role in the activation-induced cell death of B-cells (By similarity)

LOCALIZAÇÃO

NucleusCytoplasm

MECANISMO DE DOENÇA

Myoectodermal gonadal dysgenesis syndrome

An autosomal recessive disorder characterized by 46,XY complete gonadal dysgenesis and extragonadal anomalies, including typical facial gestalt, low birth weight, myopathy, rod and cone dystrophy, anal atresia, omphalocele, sensorineural hearing loss, dry and scaly skin, skeletal abnormalities, renal agenesis and neuromotor delay.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
51.6 TPM
Linfócitos
26.8 TPM
Nervo tibial
24.4 TPM
Cervix Ectocervix
24.4 TPM
Artéria tibial
23.9 TPM
OUTRAS DOENÇAS (4)
gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathyspermatogenic failure 36XY type gonadal dysgenesis-associated anomalies syndromemale infertility due to globozoospermia
HGNC:17485UniProt:Q969Q6
PAX6Paired box protein Pax-6Candidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor with important functions in the development of the eye, nose, central nervous system and pancreas. Required for the differentiation of pancreatic islet alpha cells (By similarity). Competes with PAX4 in binding to a common element in the glucagon, insulin and somatostatin promoters. Regulates specification of the ventral neuron subtypes by establishing the correct progenitor domains (By similarity). Acts as a transcriptional repressor of NFATC1-mediated gene expression (By s

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)Regulation of gene expression in beta cellsActivation of anterior HOX genes in hindbrain development during early embryogenesisFormation of the anterior neural plateSynthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
MECANISMO DE DOENÇA

Aniridia 1

A congenital, bilateral, panocular disorder characterized by complete absence of the iris or extreme iris hypoplasia. Aniridia is not just an isolated defect in iris development but it is associated with macular and optic nerve hypoplasia, cataract, corneal changes, nystagmus. Visual acuity is generally low but is unrelated to the degree of iris hypoplasia. Glaucoma is a secondary problem causing additional visual loss over time.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
40.8 TPM
Cerebelo
36.9 TPM
Córtex cerebral
3.5 TPM
Brain Caudate basal ganglia
3.4 TPM
Brain Anterior cingulate cortex BA24
3.3 TPM
OUTRAS DOENÇAS (17)
coloboma, ocular, autosomal dominantisolated optic nerve hypoplasiaautosomal dominant keratitisfoveal hypoplasia 1
HGNC:8620UniProt:P26367
NR5A1Steroidogenic factor 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional activator. Essential for sexual differentiation and formation of the primary steroidogenic tissues (PubMed:27378692). Binds to the Ad4 site found in the promoter region of steroidogenic P450 genes such as CYP11A, CYP11B and CYP21B. Also regulates the AMH/Muellerian inhibiting substance gene as well as the AHCH and STAR genes. 5'-YCAAGGYC-3' and 5'-RRAGGTCA-3' are the consensus sequences for the recognition by NR5A1 (PubMed:27378692). The SFPQ-NONO-NR5A1 complex binds to the CYP17

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (4)
Transcriptional regulation of pluripotent stem cellsNuclear Receptor transcription pathwayTranscriptional regulation of testis differentiationSUMOylation of intracellular receptors
MECANISMO DE DOENÇA

46,XY sex reversal 3

A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
221.6 TPM
Glândula adrenal
216.7 TPM
Ovário
74.6 TPM
Pituitária
33.4 TPM
Testículo
31.2 TPM
OUTRAS DOENÇAS (10)
spermatogenic failure 8premature ovarian failure 746,XX sex reversal 446,XY sex reversal 3
HGNC:7983UniProt:Q13285
NR0B1Nuclear receptor subfamily 0 group B member 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Nuclear receptor that lacks a DNA-binding domain and acts as a corepressor that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions (PubMed:12482977, PubMed:32433991). Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis (PubMed:7990953, PubMed:8675564). May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity)

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
Nuclear Receptor transcription pathway
MECANISMO DE DOENÇA

Adrenal hypoplasia, congenital

A disorder of adrenal gland development characterized by absence of the permanent zone of the adrenal cortex, structural disorganization of the adrenal glands, adrenal insufficiency and profound hormonal deficiencies. AHC patients manifest primary adrenal failure usually in early infancy, and hypogonadotropic hypogonadism leading to absent or incomplete sexual maturation. AHC can be inherited in an X-linked or autosomal recessive pattern.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
42.5 TPM
Testículo
39.1 TPM
Ovário
4.8 TPM
Pituitária
3.5 TPM
Cervix Ectocervix
2.9 TPM
OUTRAS DOENÇAS (5)
X-linked adrenal hypoplasia congenita46,XY sex reversal 246,XY complete gonadal dysgenesis46,XX testicular disorder of sex development
HGNC:7960UniProt:P51843
ATRXTranscriptional regulator ATRXDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Involved in transcriptional regulation and chromatin remodeling. Facilitates DNA replication in multiple cellular environments and is required for efficient replication of a subset of genomic loci. Binds to DNA tandem repeat sequences in both telomeres and euchromatin and in vitro binds DNA quadruplex structures. May help stabilizing G-rich regions into regular chromatin structures by remodeling G4 DNA and incorporating H3.3-containing nucleosomes. Catalytic component of the chromatin remodeling

LOCALIZAÇÃO

NucleusChromosome, telomereNucleus, PML body

VIAS BIOLÓGICAS (2)
Inhibition of DNA recombination at telomereDefective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations
MECANISMO DE DOENÇA

Alpha-thalassemia/impaired intellectual development syndrome, X-linked

A disorder characterized by severe psychomotor retardation, facial dysmorphism, urogenital abnormalities, and alpha-thalassemia. An essential phenotypic trait are hemoglobin H erythrocyte inclusions.

OUTRAS DOENÇAS (5)
intellectual disability-hypotonic facies syndrome, X-linked, 1alpha-thalassemia-myelodysplastic syndromealpha thalassemia-X-linked intellectual disability syndromegastric neuroendocrine neoplasm
HGNC:886UniProt:P46100
SOX9Transcription factor SOX-9Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor that plays a key role in chondrocytes differentiation and skeletal development (PubMed:24038782). Specifically binds the 5'-ACAAAG-3' DNA motif present in enhancers and super-enhancers and promotes expression of genes important for chondrogenesis, including cartilage matrix protein-coding genes COL2A1, COL4A2, COL9A1, COL11A2 and ACAN, SOX5 and SOX6 (PubMed:8640233). Also binds to some promoter regions (By similarity). Plays a central role in successive steps of chondrocyte

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (7)
Deactivation of the beta-catenin transactivating complexTranscriptional regulation by RUNX2Transcriptional regulation of testis differentiationTranscriptional and post-translational regulation of MITF-M expression and activityDevelopmental Lineage of Multipotent Pancreatic Progenitor Cells
MECANISMO DE DOENÇA

Campomelic dysplasia

A rare, often lethal, osteochondrodysplasia characterized by congenital bowing and angulation of long bones. Other skeletal defects include unusually small scapula, deformed pelvis and spine, and a missing pair of ribs. Craniofacial and ear defects are common. Most patients die soon after birth due to respiratory distress which has been attributed to hypoplasia of the tracheobronchial cartilage and small thoracic cage. Up to two-thirds of affected XY individuals have genital defects or may develop as phenotypic females.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
110.7 TPM
Testículo
66.8 TPM
Brain Caudate basal ganglia
47.5 TPM
Cérebro - Amígdala
42.6 TPM
Córtex cerebral
42.6 TPM
OUTRAS DOENÇAS (8)
campomelic dysplasia46,XX sex reversal 246,XY sex reversal 1046,XY complete gonadal dysgenesis
HGNC:11204UniProt:P48436
ARAndrogen receptorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues (PubMed:19022849). Transcription factor activity is modulated by bound coactivator and corepressor proteins like ZBTB7A that recruits NCOR1 and NCOR2 to the androgen response elements/ARE on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). Tran

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (6)
RUNX2 regulates osteoblast differentiationActivated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligandNuclear Receptor transcription pathwaySUMOylation of intracellular receptors
MECANISMO DE DOENÇA

Androgen insensitivity syndrome

An X-linked recessive form of pseudohermaphroditism due end-organ resistance to androgen. Affected males have female external genitalia, female breast development, blind vagina, absent uterus and female adnexa, and abdominal or inguinal testes, despite a normal 46,XY karyotype.

OUTRAS DOENÇAS (7)
Kennedy diseasehypospadias 1, X-linkedandrogen insensitivity syndromepartial androgen insensitivity syndrome
HGNC:644UniProt:P10275
CYP11A1Cholesterol side-chain cleavage enzyme, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

A cytochrome P450 monooxygenase that catalyzes the side-chain hydroxylation and cleavage of cholesterol to pregnenolone, the precursor of most steroid hormones (PubMed:21636783). Catalyzes three sequential oxidation reactions of cholesterol, namely the hydroxylation at C22 followed with the hydroxylation at C20 to yield 20R,22R-hydroxycholesterol that is further cleaved between C20 and C22 to yield the C21-steroid pregnenolone and 4-methylpentanal (PubMed:21636783). Mechanistically, uses molecul

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Endogenous sterolsPregnenolone biosynthesis
MECANISMO DE DOENÇA

Adrenal insufficiency, congenital, with 46,XY sex reversal

A rare disorder that can present as acute adrenal insufficiency in infancy or childhood. ACTH and plasma renin activity are elevated and adrenal steroids are inappropriately low or absent; the 46,XY patients have female external genitalia, sometimes with clitoromegaly. The phenotypic spectrum ranges from prematurity, complete underandrogenization, and severe early-onset adrenal failure to term birth with clitoromegaly and later-onset adrenal failure. Patients with congenital adrenal insufficiency do not manifest the massive adrenal enlargement typical of congenital lipoid adrenal hyperplasia.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
1056.4 TPM
Ovário
68.9 TPM
Testículo
47.5 TPM
Esôfago - Mucosa
8.1 TPM
Baço
6.5 TPM
OUTRAS DOENÇAS (2)
Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyinherited isolated adrenal insufficiency due to partial CYP11A1 deficiency
HGNC:2590UniProt:P05108
GATA4Transcription factor GATA-4Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional activator that binds to the consensus sequence 5'-AGATAG-3' and plays a key role in cardiac development and function (PubMed:24000169, PubMed:27984724, PubMed:35182466). In cooperation with TBX5, it binds to cardiac super-enhancers and promotes cardiomyocyte gene expression, while it down-regulates endocardial and endothelial gene expression (PubMed:27984724). Involved in bone morphogenetic protein (BMP)-mediated induction of cardiac-specific gene expression. Binds to BMP respons

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (10)
Developmental Lineage of Pancreatic Acinar CellsDevelopmental Lineage of Multipotent Pancreatic Progenitor CellsDevelopmental Lineage of Pancreatic Ductal CellsSynthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)Cardiogenesis
MECANISMO DE DOENÇA

Atrial septal defect 2

A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. Patients show other heart abnormalities including ventricular and atrioventricular septal defects, pulmonary valve thickening or insufficiency of the cardiac valves. The disease is not associated with defects in the cardiac conduction system or non-cardiac abnormalities.

EXPRESSÃO TECIDUAL(Tecido-específico)
Ovário
144.1 TPM
Coração - Átrio
53.7 TPM
Testículo
51.1 TPM
Coração - Ventrículo esquerdo
45.2 TPM
Artéria coronária
40.7 TPM
OUTRAS DOENÇAS (12)
tetralogy of fallotventricular septal defect 1testicular anomalies with or without congenital heart diseaseatrial septal defect 2
HGNC:4173UniProt:P43694
DHHDesert hedgehog proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

The C-terminal part of the desert hedgehog protein precursor displays an autoproteolysis and a cholesterol transferase activity (By similarity). Both activities result in the cleavage of the full-length protein into two parts (N-product and C-product) followed by the covalent attachment of a cholesterol moiety to the C-terminal of the newly generated N-product (DHH-N) (By similarity). Both activities occur in the endoplasmic reticulum (By similarity). Once cleaved, the C-product is degraded in t

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneGolgi apparatus membraneSecreted

VIAS BIOLÓGICAS (5)
Hedgehog 'on' stateActivation of SMOLigand-receptor interactionsRelease of Hh-Np from the secreting cellTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

46,XY gonadal dysgenesis with minifascicular neuropathy

An autosomal recessive disorder characterized by gonadal dysgenesis associated with polyneuropathy. Genital anomalies include the presence of a testis on one side and a streak or an absent gonad at the other, persistence of Muellerian duct structures, and a variable degree of genital ambiguity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Nervo tibial
58.0 TPM
Testículo
39.0 TPM
Artéria coronária
1.8 TPM
Rim - Medula
1.2 TPM
Tecido adiposo
1.2 TPM
OUTRAS DOENÇAS (3)
46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome46,XY sex reversal 746,XY complete gonadal dysgenesis
HGNC:2865UniProt:O43323
ZFPM2Zinc finger protein ZFPM2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription regulator that plays a central role in heart morphogenesis and development of coronary vessels from epicardium, by regulating genes that are essential during cardiogenesis. Essential cofactor that acts via the formation of a heterodimer with transcription factors of the GATA family GATA4, GATA5 and GATA6. Such heterodimer can both activate or repress transcriptional activity, depending on the cell and promoter context. Also required in gonadal differentiation, possibly be regulatin

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Transcriptional regulation of testis differentiationFactors involved in megakaryocyte development and platelet production
MECANISMO DE DOENÇA

Tetralogy of Fallot

A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
39.2 TPM
Cerebelo
27.3 TPM
Ovário
27.0 TPM
Fallopian Tube
17.6 TPM
Útero
16.3 TPM
OUTRAS DOENÇAS (5)
tetralogy of fallot46,XY sex reversal 9diaphragmatic hernia 3congenital diaphragmatic hernia
HGNC:16700UniProt:Q8WW38
MAP3K1Mitogen-activated protein kinase kinase kinase 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of a protein kinase signal transduction cascade (PubMed:9808624). Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4 (PubMed:9808624). May phosphorylate the MAPK8/JNK1 kinase (PubMed:17761173). Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway (PubMed:9808624)

LOCALIZAÇÃO

VIAS BIOLÓGICAS (5)
FCERI mediated MAPK activationTRAF6 mediated NF-kB activationMyD88:MAL(TIRAP) cascade initiated on plasma membraneTRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activationMyD88 cascade initiated on plasma membrane
MECANISMO DE DOENÇA

46,XY sex reversal 6

A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
37.2 TPM
Skin Sun Exposed Lower leg
36.7 TPM
Tireoide
29.7 TPM
Baço
26.1 TPM
Vagina
21.2 TPM
OUTRAS DOENÇAS (3)
46,XY sex reversal 646,XY partial gonadal dysgenesis46,XY complete gonadal dysgenesis
HGNC:6848UniProt:Q13233
HSD17B317-beta-hydroxysteroid dehydrogenase type 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the conversion of 17-oxosteroids to 17beta-hydroxysteroids (PubMed:16216911, PubMed:26545797, PubMed:27927697, PubMed:8075637). Favors the reduction of androstenedione to testosterone (PubMed:16216911, PubMed:26545797, PubMed:27927697). Testosterone is the key androgen driving male development and function (PubMed:8075637). Uses NADPH while the two other EDH17B enzymes use NADH (PubMed:16216911, PubMed:26545797, PubMed:8075637). Androgens such as epiandrosterone, dehydroepiandrosterone

LOCALIZAÇÃO

Endoplasmic reticulum

VIAS BIOLÓGICAS (2)
Androgen biosynthesisSynthesis of very long-chain fatty acyl-CoAs
MECANISMO DE DOENÇA

Male pseudohermaphrodism with gynecomastia

An autosomal recessive disorder that manifests, in males, as undermasculinization characterized by hypoplastic-to-normal internal genitalia (epididymis, vas deferens, seminal vesicles, and ejaculatory ducts) but female external genitalia and the absence of a prostate. This phenotype is caused by inadequate testicular synthesis of testosterone, which, in turn, results in insufficient formation of dihydrotestosterone in the anlage of the external genitalia and prostate during fetal development. At the expected time of puberty, there is a marked increase in plasma leuteinizing hormone and, consequently, in testicular secretion of androstenedione. Hence, a diagnostic hallmark of this disorder is a decreased plasma testosterone-to-androstenedione ratio. Significant amounts of the circulating androstenedione are, however, converted to testosterone, in peripheral tissues, thereby causing virilization.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
41.3 TPM
Tireoide
13.9 TPM
Nervo tibial
13.8 TPM
Brain Spinal cord cervical c-1
8.4 TPM
Fígado
6.5 TPM
OUTRAS DOENÇAS (1)
46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
HGNC:5212UniProt:P37058
HHATProtein-cysteine N-palmitoyltransferase HHATDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Palmitoyl acyltransferase that catalyzes N-terminal palmitoylation of SHH; which is required for SHH signaling (PubMed:18534984, PubMed:24784881, PubMed:31875564). It also catalyzes N-terminal palmitoylation of DHH (PubMed:24784881). Promotes the transfer of palmitoyl-CoA from the cytoplasmic to the luminal side of the endoplasmic reticulum membrane, where SHH palmitoylation occurs (PubMed:31875564). It is an essential factor for proper embryonic development and testicular organogenesis (PubMed:

LOCALIZAÇÃO

Endoplasmic reticulum membraneGolgi apparatus membrane

VIAS BIOLÓGICAS (1)
Hedgehog ligand biogenesis
MECANISMO DE DOENÇA

Nivelon-Nivelon-Mabille syndrome

An autosomal recessive syndrome characterized by progressive microcephaly, cerebellar vermis hypoplasia, and skeletal dysplasia. Additional variable features include early infantile-onset seizures, intrauterine and postnatal growth retardation, generalized chondrodysplasia, and micromelia. 46,XY gonadal dysgenesis may be present.

EXPRESSÃO TECIDUAL(Baixa expressão)
Tireoide
4.9 TPM
Glândula adrenal
4.8 TPM
Cervix Endocervix
4.4 TPM
Próstata
3.9 TPM
Glândula salivar
3.8 TPM
OUTRAS DOENÇAS (1)
chondrodysplasia-pseudohermaphroditism syndrome
HGNC:18270UniProt:Q5VTY9
WT1Wilms tumor proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor that plays an important role in cellular development and cell survival (PubMed:7862533). Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3' (PubMed:17716689, PubMed:25258363, PubMed:7862533). Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may a

LOCALIZAÇÃO

NucleusNucleus, nucleolusCytoplasmNucleus speckleNucleus, nucleoplasm

VIAS BIOLÓGICAS (3)
Nephron developmentNegative Regulation of CDH1 Gene TranscriptionTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

Frasier syndrome

Characterized by a slowly progressing nephropathy leading to renal failure in adolescence or early adulthood, male pseudohermaphroditism, and no Wilms tumor. As for histological findings of the kidneys, focal glomerular sclerosis is often observed. There is phenotypic overlap with Denys-Drash syndrome. Inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Útero
109.7 TPM
Fallopian Tube
75.2 TPM
Ovário
65.2 TPM
Testículo
40.5 TPM
Adipose Visceral Omentum
30.0 TPM
OUTRAS DOENÇAS (12)
Wilms tumor 1nephrotic syndrome, type 4Meacham syndromemalignant mesothelioma
HGNC:12796UniProt:P19544
TSPYL1Testis-specific Y-encoded-like protein 1Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

Nucleus, nucleolus

MECANISMO DE DOENÇA

Sudden infant death with dysgenesis of the testes syndrome

Autosomal recessive disorder. Affected infants appear normal at birth, develop signs of visceroautonomic dysfunction early in life, and die before 12 months of age of abrupt cardiorespiratory arrest. Features included bradycardia, hypothermia, severe gastroesophageal reflux, laryngospasm, bronchospasm, and abnormal cardiorespiratory patterns during sleep. Genotypic males with SIDDT had fetal testicular dysgenesis and ambiguous genitalia, with findings such as intraabdominal testes, dysplastic testes, deficient fetal testosterone production, fusion and rugation of the gonadal sac, and partial development of the penile shaft. Female sexual development was normal. Affected infants had an unusual staccato cry, similar to the cry of a goat.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
243.9 TPM
Brain Frontal Cortex BA9
224.4 TPM
Cerebelo
170.5 TPM
Brain Nucleus accumbens basal ganglia
136.9 TPM
Córtex cerebral
129.7 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
sudden infant death-dysgenesis of the testes syndrome
HGNC:12382UniProt:Q9H0U9

Variantes genéticas (ClinVar)

556 variantes patogênicas registradas no ClinVar.

🧬 SRD5A2: NM_000348.4(SRD5A2):c.453del (p.Leu152fs) ()
🧬 SRD5A2: NM_000348.4(SRD5A2):c.354C>G (p.Phe118Leu) ()
🧬 SRD5A2: NM_000348.4(SRD5A2):c.445+1G>A ()
🧬 SRD5A2: NM_000348.4(SRD5A2):c.554T>A (p.Leu185Ter) ()
🧬 SRD5A2: NM_000348.4(SRD5A2):c.269A>G (p.His90Arg) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

85 vias biológicas associadas aos genes desta condição.

Androgen biosynthesis rRNA modification in the nucleus and cytosol Major pathway of rRNA processing in the nucleolus and cytosol Nuclear signaling by ERBB4 Negative regulation of activity of TFAP2 (AP-2) family transcription factors Activation of the TFAP2 (AP-2) family of transcription factors trans-Golgi Network Vesicle Budding Lysosome Vesicle Biogenesis Golgi Associated Vesicle Biogenesis Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Interleukin-12 signaling Synthesis of PIPs at the plasma membrane Synthesis of PIPs at the early endosome membrane Synthesis of PIPs at the late endosome membrane Deactivation of the beta-catenin transactivating complex Transcriptional regulation of testis differentiation Pre-NOTCH Transcription and Translation Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells NOTCH1 Intracellular Domain Regulates Transcription NOTCH2 intracellular domain regulates transcription Constitutive Signaling by NOTCH1 PEST Domain Mutants Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants Notch-HLH transcription pathway RUNX3 regulates NOTCH signaling NOTCH3 Intracellular Domain Regulates Transcription NOTCH4 Intracellular Domain Regulates Transcription Formation of paraxial mesoderm PIP3 activates AKT signaling Constitutive Signaling by Aberrant PI3K in Cancer PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling MECP2 regulates transcription of neuronal ligands BDNF activates NTRK2 (TRKB) signaling Activated NTRK2 signals through RAS Activated NTRK2 signals through PLCG1 Activated NTRK2 signals through PI3K Activated NTRK2 signals through FRS2 and FRS3 Activated NTRK2 signals through FYN NTRK2 activates RAC1 Activated NTRK2 signals through CDK5 NPAS4 regulates expression of target genes Regulation of gene expression in beta cells Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) Activation of anterior HOX genes in hindbrain development during early embryogenesis Formation of the anterior neural plate Nuclear Receptor transcription pathway SUMOylation of intracellular receptors Transcriptional regulation of pluripotent stem cells Inhibition of DNA recombination at telomere Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations Transcriptional regulation by RUNX2 Transcriptional and post-translational regulation of MITF-M expression and activity Developmental Lineage of Pancreatic Acinar Cells Developmental Lineage of Pancreatic Ductal Cells Developmental Lineage of Multipotent Pancreatic Progenitor Cells HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 Ub-specific processing proteases RUNX2 regulates osteoblast differentiation Pregnenolone biosynthesis Endogenous sterols Defective CYP11A1 causes AICSR YAP1- and WWTR1 (TAZ)-stimulated gene expression Physiological factors Cardiogenesis Formation of lateral plate mesoderm Formation of definitive endoderm Factors involved in megakaryocyte development and platelet production Class B/2 (Secretin family receptors) Hedgehog ligand biogenesis Release of Hh-Np from the secreting cell Ligand-receptor interactions Hedgehog 'on' state Activation of SMO HHAT G278V doesn't palmitoylate Hh-Np MyD88:MAL(TIRAP) cascade initiated on plasma membrane FCERI mediated MAPK activation TRAF6 mediated NF-kB activation TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation MyD88 cascade initiated on plasma membrane Synthesis of very long-chain fatty acyl-CoAs Negative Regulation of CDH1 Gene Transcription Nephron development

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença do desenvolvimento sexual 46,XY

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Identification of Novel and Known Variants in Epigenetic Genes Associated with Syndromic 46,XY Differences of Sex Development among Moroccan Patients.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation2026

46,XY differences of sex development (DSD) are conditions with extreme phenotypic and genetic heterogeneity. Therefore, their diagnosis remains a major challenge for both clinicians and geneticists. In this study, we aimed to identify the underlying genetic causes of DSD in a series of 3 Moroccan patients with syndromic 46,XY DSD recruited in the BRO Biobank. Methods: Karyotyping analysis was performed on peripheral blood samples using standard R banding techniques. SRY gene was analyzed using PCR amplification followed by Sanger sequencing. Whole exome sequencing (WES) was performed after unsuccessful conventional genetic analyses. Candidate variants were evaluated by segregation analysis and molecular modeling. WES identified three pathogenic variants in genes encoding various components of the epigenetic machinery: in patient 1, a novel heterozygous frameshift variant c.4072dup (p.Glu1358GlyfsTer29) in the KAT6B gene associated with two clinically distinct syndromes (genitopatellar syndrome and Say-Barber-Biesecker-Young-Simpson syndrome) was detected; in patient 2, we identified a previously reported de novo heterozygous nonsense variant c.12943C>T (p.Gln4315Ter) in KMT2D responsible for Kabuki syndrome; in patient 3, WES revealed a novel heterozygous missense variant c.4056C>G (p.Phe1352Leu) in CHD7 responsible for CHARGE syndrome. We discuss the genotype-phenotype correlation in these syndromic 46,XY DSD and discuss the relevance of the epigenetic genes in sexual development. Our findings highlight the utility of WES in discriminating clinically overlapping syndromic 46,XY DSD to provide an accurate diagnosis, thus allowing better follow-up and appropriate patient management. In addition, our study enriched the mutational spectrum of syndromic 46,XY DSD and confirmed the genotype-phenotype correlations.

#2

Rare phenotypic spectrum of 17β-hydroxysteroid dehydrogenase 3 deficiency: case series from infancy to adolescence.

Journal of pediatric endocrinology &amp; metabolism : JPEM2026 Mar 26

17β-Hydroxysteroid dehydrogenase 3 (17β-HSD3) deficiency is a rare 46XY disorder of sex development (DSD) of androgen biosynthesis. We aimed to describe the complexities in diagnosis, gender assignment, and the timing of irreversible surgical interventions in 17β-HSD3 deficiency. We described three genetically confirmed cases of 46XY DSD due to 17β-HSD3 deficiency. All of them had female-appearing external genitalia, and the third case had well-developed breasts with clitoromegaly. The biochemical evaluation showed hCG-stimulated T/A ratios of 0.4 and 0.35 in Cases 1 and 2, respectively, and an unstimulated T/A ratio of 0.25 in Case 3. Molecular analysis revealed three different HSD17B3 variants: c.72C>A(p.Cys24Ter), c.764C>T(p.Ser255Leu), and c.607-1G>A(3'splice site) in the respective cases. Despite the female-appearing external genitalia in Case 1, the parents decided to rear the child as male, whereas Cases 2 and 3 retained a female gender identity. The first two cases were advised to have regular follow-up for gender dysphoria, while Case 3 was managed with injectable leuprolide depot and anti-androgens. 17β-HSD3 deficiency remains a challenging 46 XY DSD due to its clinical heterogeneity and diverse molecular spectrum. This report adds to current molecular knowledge by reporting two novel variants in the HSD17B3 gene.

#3

Upstream SOX9 deletion in a 46,XY girl with acampomelic campomelic dysplasia and absent minipuberty.

Orphanet journal of rare diseases2025 Nov 22

Campomelic dysplasia (CD) is a rare congenital skeletal dysplasia frequently associated with differences of sex development (DSD). In about 10% of affected individuals, the bowing of the long bones (campomelia) is absent, referred to as acampomelic campomelic dysplasia (ACD). Most patients with ACD carry heterozygous pathogenic variants within the SOX9 coding region or balanced chromosomal rearrangements involving the 17q24 region. A rarer mechanism involves deletions located upstream of the SOX9 gene. Only five ACD cases with upstream deletions of SOX9 have been reported in the medical literature. We report a female patient affected by ACD with Pierre Robin sequence, complete gonadal dysgenesis (CGD), and hypotonia. Genetic testing revealed a de novo 1.671 Mb deletion located 191 kb upstream of the SOX9 gene. This chromosomal aberration represents the second-largest deletion upstream of SOX9 reported to date. In addition, we describe the patient's endocrine profile, which revealed an absent gonadotropin rise during minipuberty, followed by a delayed increase in infancy. This study expands the clinical and molecular spectrum of ACD, enhancing our understanding of genotype-phenotype correlations of this condition. The phenotypic and endocrinological description of the proband may be helpful for clinicians who consult patients with DSD and skeletal dysplasia.

#4

Molecular genetic diagnosis and surgical management in a cohort of children with 46,XY disorders/differences of sex development.

Frontiers in pediatrics2025

A firm diagnosis revealing the etiology of disorders/differences of sex development (DSD) is most helpful in guiding clinical management. The aim of this study is to investigate molecular genetic diagnoses and surgical treatment in a cohort of children with 46,XY DSD. A retrospective study was conducted on children with 46,XY DSD. They were referred to a tertiary surgical center during the period between 2011 and 2022 and were found to have genetic alterations, which were considered etiologies for their DSD. Data on clinical presentations, sex of rearing, genetic findings, surgical treatment, and comorbidities were collected and reviewed. A total of 21 patients were included in the study: 11 and 10 were reared as male and female, respectively. Genetic alterations were found as the causes for androgen insensitivity syndrome (n = 4), 5-alpha reductase type II deficiency (n = 5), 17-beta hydroxysteroid dehydrogenase III deficiency (n = 1), 17-alpha hydroxylase deficiency (n = 1), and gonadal dysgenesis (n = 10). Of those with gonadal dysgenesis, the genetic alterations were NR5A1 mutation/deletion (n = 3), DMRT1 deletion (n = 4), WT1 mutation (n = 2), and DAX1 duplication (n = 1). A total of 20/21 patients underwent one or more surgical procedures including hypospadias repair (n = 10), gonadectomy (n = 11), gonadal biopsy (n = 4), hernia repair (n = 4), orchidopexy (n = 1), and feminizing genitoplasty (n = 1). A total of 5/21 had germ cell neoplasms in one or both gonads. A total of 8/10 patients with gonadal dysgenesis had comorbidities involving other systems. Of the whole group, seven patients were found to inherit genetic alterations from their parents. Molecular genetic diagnosis enhances the understanding of etiology, improves diagnostic accuracy, and provides precise guidance in the counseling and surgical management of children with 46,XY DSD.

#5

Functional analysis of SRY variants in individuals with 46,XY differences of sex development.

Molecular and cellular endocrinology2025 Mar 01

In mammals, male sexual development is initiated by the expression of the Sex-determining-Region-Y (SRY) gene. SRY contains a highly conserved high mobility group (HMG) box essential for DNA binding and activity. Variants in SRY cause Differences of Sex Development (DSD), accounting for 10-15% of 46, XY gonadal dysgenesis cases. Here, we present the functional analysis of five SRY coding variants identified in patients with 46, XY DSD. Four variants (p.Asp58Glu, p.Arg75Lys, p.Met85Thr, and p.Arg86Ter) are located within the HMG box and one variant (p.Tyr198Cysfs∗18) located in the C-terminal domain. We functionally characterise the impact of these variants in vitro, investigating SRY localisation and transactivational activity using SOX9 regulatory elements that are responsive to SRY. We find that three variants (p.Met85Thr, p.Arg86Ter, and p.Tyr198Cysfs∗18) have reduced or abolished transactivational activity suggesting these are pathogenic, with the p.Arg86Ter variant undetectable in our assays and the p.Met85Thr variant exhibiting reduced nuclear localisation. The pathogenic mechanisms underlying reduced activity of the novel elongated p.Tyr198Cysfs∗18 variant is however unclear, although this variant also affected localisation. In contrast, two additional variants (p.Asp58Glu and p.Arg75Lys) had no discernible effects on nuclear localisation or transactivational activity despite in silico analysis predicting impaired DNA binding. Taken together, our data establish the likely pathogenicity of these SRY variants and improve diagnostic certainty for the patients in which they were identified.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC2 artigos no totalmostrando 200

2026

Identification of Novel and Known Variants in Epigenetic Genes Associated with Syndromic 46,XY Differences of Sex Development among Moroccan Patients.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2025

[Clinical, hormonal and molecular genetic characteristics of 18 cases of disorders of sex development (DSD) 46,XY associated with variants in the SRD5A2 gene].

Problemy endokrinologii
2026

Rare phenotypic spectrum of 17β-hydroxysteroid dehydrogenase 3 deficiency: case series from infancy to adolescence.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

Testicular cytology and semen analysis in 46, XY differences/disorders of sex development (DSD): implications for fertility.

Pediatric surgery international
2025

Clinical Spectrum, Surgical Management, and Outcomes of NR5A1-Related 46,XY Differences of Sex Development: A Narrative Review.

Medicina (Kaunas, Lithuania)
2025

Upstream SOX9 deletion in a 46,XY girl with acampomelic campomelic dysplasia and absent minipuberty.

Orphanet journal of rare diseases
2025

Maternal Microchimerism Is Uncommon in Patients with Hypospadias.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2025

Isodicentric Y chromosome with SRY duplication in a female with complete gonadal dysgenesis.

Molecular cytogenetics
2025

Close relationship, similar phenotype of GATA4 and NR5A1 mutations: gonadal dysgenesis and puberty development.

Journal of endocrinological investigation
2025

The diagnostic value of stimulated androgen ratios in 5-alpha reductase type 2 (SRD5A2) deficiency: a case series and review of the literature.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

Persistent Müllerian Duct Syndrome and Concurrent Pre-Germ Cell Neoplasia In Situ.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2025

Case Report: De novo DHX37 mutations in Saudi patients with 46,XY differences of sex development.

Frontiers in endocrinology
2025

Excision versus division of Müllerian duct remnants in male disorders of sexual development and differentiation: a prospective study to generate anatomical assessment criteria.

Pediatric surgery international
2025

Pubertal Development as a Marker of Gonadal Neoplasm in 46XY Complete Gonadal Dysgenesis.

Journal of pediatric and adolescent gynecology
2025

Amplicon-based targeted next-generation sequencing using dried blood spots for 46,XY differences/disorders of sex development: Aiming for diagnosis by minimally invasive testing.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2025

Prevalence of Differences of Sex Development Among Pediatric Endocrine Care Centers in Switzerland From 2000 to 2019.

Journal of the Endocrine Society
2025

46,XY 17 alpha-hydroxylase/17,20 lyase deficiency with breast development: A case report and literature review.

Endocrine journal
2025

Novel SOX9 Gene Variant Associated with Campomelic Dysplasia: Effects on Sex Phenotypes.

Journal of clinical research in pediatric endocrinology
2025

Coproporphyrinogen Oxidase Deficiency Causes Primary Adrenal Insufficiency and 46,XY DSD.

The Journal of clinical endocrinology and metabolism
2025

Estrogen-secreting testicular tumors in 46,XY female patients with 17α-hydroxylase/17,20-lyase deficiency: two unusual case reports and a review of the literature.

Frontiers in genetics
2025

46, XY under-virilization and NR5A1 variants: Monocentric Indian experience and systematic review.

Annales d'endocrinologie
2025

Phenotypic Variation and Pubertal Outcomes in Males and Females With 46,XY Partial Gonadal Dysgenesis.

The Journal of clinical endocrinology and metabolism
2025

Oligogenic analysis across broad phenotypes of 46,XY differences in sex development associated with NR5A1/SF-1 variants: findings from the international SF1next study.

EBioMedicine
2025

Profile of DHX37 gene defects in human genetic diseases: 46,XY disorders of sex development.

Frontiers in endocrinology
2025

Microscopic testicular sperm extraction in 46, XY differences in sex development caused by 5-alpha reductase type 2 deficiency.

Archives of endocrinology and metabolism
2025

Molecular genetic diagnosis and surgical management in a cohort of children with 46,XY disorders/differences of sex development.

Frontiers in pediatrics
2025

MYRF Variants in Patients With 46,XY Differences/Disorders of Sex Development and Literature Review.

American journal of medical genetics. Part A
2025

46, XY Complete Gonadal Dysgenesis (Swyer Syndrome) Presenting as Primary Amenorrhea in a Normomorphic Adult Female From Kakamega, Kenya.

Clinical case reports
2025

Functional analysis of SRY variants in individuals with 46,XY differences of sex development.

Molecular and cellular endocrinology
2025

Gonadal function and pathology in 17beta-HSD 3 and 5alpha-reductase deficiency.

European journal of endocrinology
2025

A novel CUL4B gene variant activating Wnt4/β-catenin signal pathway to karyotype 46, XY female with disorders of sex development.

Biological research
2024

Clinical spectrum and molecular basis in 19 Chinese patients with 46, XY disorder of sexual development caused by NR5A1 mutations.

Orphanet journal of rare diseases
2025

Genetic and Clinical Characteristics of 185 Japanese Children With 46,XY Differences of Sex Development.

The Journal of clinical endocrinology and metabolism
2024

Experiences and psychological issues affecting parents of children born with atypical genitalia in India.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2024

Gly183Ser homozygous mutation of the steroid 5-a reductase type 2 (SRD5A2) gene in a Brazilian patient: case report.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2024

NR5A1/SF-1 Collaborates with Inhibin α and the Androgen Receptor.

International journal of molecular sciences
2024

Application and insights of targeted next-generation sequencing in a large cohort of 46,XY disorders of sex development in Chinese.

Biology of sex differences
2024

Evidence for NR2F2/COUP-TFII involvement in human testis development.

Scientific reports
2025

Genomic technologies and the diagnosis of 46, XY differences of sex development.

Andrology
2024

Characteristic external genitalia in male neonates with 5α-reductase deficiency.

Endocrine journal
2024

Recommendations for 46,XY Disorders/Differences of Sex Development Across Two Decades: Insights from North American Pediatric Endocrinologists and Urologists.

Archives of sexual behavior
2024

Worldwide cohort study of 46, XY differences/disorders of sex development genetic diagnoses: geographic and ethnic differences in variants.

Frontiers in genetics
2024

Detection of Molecular Variations at Androgen Receptor Gene in 46,XY Differences in Sex Development Cases.

Indian journal of endocrinology and metabolism
2024

Endometriosis in a Prepubertal Patient with 46,XY Difference in Sex Development: A Case Report.

Journal of pediatric and adolescent gynecology
2024

Long-term outcome of gender assignment in individuals with 46, XY DSD assigned female sex in multicultural society.

Journal of pediatric urology
2024

Clinical characteristics and surgical treatment of children with 45, X/46, XY differences of sex development.

Journal of pediatric urology
2023

Mutations in STARD8 (DLC3) May Cause 46,XY Gonadal Dysgenesis.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2024

[Value of the human chorionic gonadotropin stimulation test in the diagnosis of disorder of sexual development in children].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2024

A Risk of Gonadoblastoma in Familial Swyer Syndrome-A Case Report and Literature Review.

Journal of clinical medicine
2023

NR5A1-related 46,XY partial gonadal dysgenesis: A case report and literature review.

Medicine
2024

DHX37 and the Implications in Disorders of Sex Development: An Update Review.

Hormone research in paediatrics
2024

Long-read genome sequencing reveals a novel intronic retroelement insertion in NR5A1 associated with 46,XY differences of sexual development.

American journal of medical genetics. Part A
2023

Persistent Müllerian Duct Syndrome Diagnosed Incidentally: A Case Report.

JPMA. The Journal of the Pakistan Medical Association
2023

In vitro functional study of fifteen SRD5A2 variants found in Chinese patients and the relation between the SRD5A2 genotypes and phenotypes.

The Journal of steroid biochemistry and molecular biology
2023

DMRT1 is a testis-determining gene in rabbits and is also essential for female fertility.

eLife
2023

Mini review: Breast cancer care in individuals with differences of sexual development.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2023

Intersex manifestation in the rainbow darter (Etheostoma caeruleum): Are adult male fish susceptible to developing and recovering from intersex after exposure to endocrine active compounds?

Aquatic toxicology (Amsterdam, Netherlands)
2023

A novel mutation in the AMHR2 gene, resulting in persistent Müllerian duct syndrome presenting with bilateral cryptorchidism and obstructed inguinal hernia.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2023

Induced pluripotent stem cell line generated from a patient with differences in sex development (DSD) and multiple genetic variants including a large deletion in NR5A1.

Stem cell research
2023

Disorders of Sex Development in Office Practice.

Indian journal of pediatrics
2023

Genotype-phenotype correlations, surgical selections, and postoperative complications of 5α-reductase 2 deficiency in 69 children with hypospadias.

Asian journal of andrology
2023

Nuclear Receptor Gene Variants Underlying Disorders/Differences of Sex Development through Abnormal Testicular Development.

Biomolecules
2023

"Exogenous" 5 Alpha Reductase Deficiency: A Case Report.

Urology
2024

The genetic spectrum of a Chinese series of patients with 46, XY disorders of the sex development.

Andrology
2023

A novel DEAH-box helicase 37 mutation associated with differences of sex development.

Frontiers in endocrinology
2023

Genetic control of typical and atypical sex development.

Nature reviews. Urology
2023

New molecular insights into the A218V variant impact on the steroidogenic acute regulatory protein (STAR) associated with 46, XY disorders of sexual development.

Molecular genetics and genomics : MGG
2023

Sexuality and fertility desire in a large cohort of individuals with 46, XY differences in sex development.

Clinics (Sao Paulo, Brazil)
2023

Genetic Variants in SRD5A2 in a Spectrum of DSD Patients from Australian Clinics Highlight Importance of Genetic Testing alongside Typical First-Line Investigations.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2023

Persistence of foetal testicular features in patients with defective androgen signalling.

European journal of endocrinology
2023

Additional evidence for the role of chromosomal imbalances and SOX8, ZNRF3 and HHAT gene variants in early human testis development.

Reproductive biology and endocrinology : RB&amp;E
2023

Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up.

BMC endocrine disorders
2023

Changes in the clinical management of 5α-reductase type 2 and 17β-hydroxysteroid dehydrogenase type 3 deficiencies in France.

Endocrine connections
2022

Challenges in the Diagnosis of XY Differences of Sexual Development.

Medicina (Kaunas, Lithuania)
2023

Challenges Waiting for an Adult with DSD.

Hormone research in paediatrics
2023

Diagnostic approach in 46, XY DSD: an endocrine society of bengal (ESB) consensus statement.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2022

Clinical characteristics of a male child with non-classic lipoid congenital adrenal hyperplasia and literature review.

Frontiers in endocrinology
2022

Elevated plasma miR-210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development.

Molecular genetics &amp; genomic medicine
2023

FGF9 variant in 46,XY DSD patient suggests a role for dimerization in sex determination.

Clinical genetics
2022

An Asian case of combined 17α-hydroxylase/17,20-lyase deficiency due to homozygous p.R96Q mutation: A case report and review of the literature.

Frontiers in endocrinology
2022

A conserved function of Human DLC3 and Drosophila Cv-c in testis development.

eLife
2022

Novel variant in HHAT as a cause of different sex development with partial gonadal dysgenesis associated with microcephaly, eye defects, and distal phalangeal hypoplasia of both thumbs: Case report.

Frontiers in endocrinology
2023

Lessons from 17β-HSD3 deficiency: Clinical spectrum and complex molecular basis in Chinese patients.

The Journal of steroid biochemistry and molecular biology
2022

Disorder of Sex Development Due to 17-Beta-Hydroxysteroid Dehydrogenase Type 3 Deficiency: A Case Report and Review of 70 Different HSD17B3 Mutations Reported in 239 Patients.

International journal of molecular sciences
2023

Anomalies in Human Sex Determination: Usefulness of a Combined Cytogenetic Approach to Characterize an Additional Case with Xp Functional Disomy Associated with 46,XY Gonadal Dysgenesis.

Journal of clinical research in pediatric endocrinology
2022

Tenuous Transcriptional Threshold of Human Sex Determination. I. SRY and Swyer Syndrome at the Edge of Ambiguity.

Frontiers in endocrinology
2022

DHX37 and 46,XY DSD: A New Ribosomopathy?

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2022

Case Report: Novel Compound Heterozygotic Variants in PPP2R3C Gene Causing Syndromic 46, XY Gonadal Dysgenesis and Literature Review.

Frontiers in genetics
2022

The Molecular Basis of 5α-Reductase Type 2 Deficiency.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2022

Can Non-Coding NR5A1 Gene Variants Explain Phenotypes of Disorders of Sex Development?

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2022

A case of 46,XY disorders of sex development with congenital heart disease caused by a GATA4 variant.

Congenital anomalies
2022

Non-obvious diagnosis and breast development in pure gonadal dysgenesis.

Ginekologia polska
2022

Clinical, Hormonal, and Genetic Characteristics of 5α-Reductase Type 2 Deficiency in 103 Chinese Patients.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
2022

46, XY Disorders of Sexual Development: a case report and theoretical framework.

Acta bio-medica : Atenei Parmensis
2023

Cell adhesion and immune response, two main functions altered in the transcriptome of seasonally regressed testes of two mammalian species.

Journal of experimental zoology. Part B, Molecular and developmental evolution
2022

Disorders of Sex Development in a Large Ukrainian Cohort: Clinical Diversity and Genetic Findings.

Frontiers in endocrinology
2022

A rare cause of primary amenorrhea: LHCGR gene mutations.

European journal of obstetrics, gynecology, and reproductive biology
2022

Effectiveness of dihydrotestosterone ointment on glans penis size increment in a 5-alpha-reductase type 2 deficiency patient.

Pediatrics international : official journal of the Japan Pediatric Society
2022

Fertility in Individuals with Differences in Sex Development: Provider Knowledge Assessment.

Journal of pediatric and adolescent gynecology
2022

Genetics of 46,XY gonadal dysgenesis.

Best practice &amp; research. Clinical endocrinology &amp; metabolism
2022

Genetics of anti-Müllerian hormone and its signaling pathway.

Best practice &amp; research. Clinical endocrinology &amp; metabolism
2022

17β hydroxysteroid dehydrogenase 3 deficiency in 46,XY disorders of sex development: Our experience and a gender role-focused systematic review.

Clinical endocrinology
2022

Contribution of Clinical and Genetic Approaches for Diagnosing 209 Index Cases With 46,XY Differences of Sex Development.

The Journal of clinical endocrinology and metabolism
2023

Unraveling a case of 46,XY DSD due to 17ß-Hydroxysteroid Dehydrogenase type 3 mutations at the age of 49.

Annales d'endocrinologie
2022

Sexual Function in Women With Differences of Sex Development or Premature Loss of Gonadal Function.

The journal of sexual medicine
2022

Surgical management and molecular diagnosis of persistent Müllerian duct syndrome in Chinese patients.

Asian journal of andrology
2021

Chronic social defeat stress causes retinal vascular dysfunction.

Experimental eye research
2022

Differences of adrenal-derived androgens in 5α-reductase deficiency versus androgen insensitivity syndrome.

Clinical and translational science
2022

Expanding the spectrum of syndromic PPP2R3C-related XY gonadal dysgenesis to XX gonadal dysgenesis.

Clinical genetics
2022

Clinical, Biochemical, and Molecular Characterization of Indian Children with Clinically Suspected Androgen Insensitivity Syndrome.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2021

One hundred twelve cases of 46, XY DSD patients after initial gender assignment: a short-term survey of gender role and gender dysphoria.

Orphanet journal of rare diseases
2022

Pubertal development in 46,XY patients with NR5A1 mutations.

Endocrine
2022

Clinical Utility of Anti-Mullerian Hormone in Pediatrics.

The Journal of clinical endocrinology and metabolism
2023

Oligogenic Causes of Human Differences of Sex Development: Facing the Challenge of Genetic Complexity.

Hormone research in paediatrics
2022

Variants in 46,XY DSD-Related Genes in Syndromic and Non-Syndromic Small for Gestational Age Children with Hypospadias.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2022

The Desert Hedgehog Signalling Pathway in Human Gonadal Development and Differences of Sex Development.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2022

A Small Supernumerary Xp Marker Chromosome Including Genes NR0B1 and MAGEB Causing Partial Gonadal Dysgenesis and Gonadoblastoma.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2021

Clinical, Hormonal, Genetic, and Molecular Characteristics in Androgen Insensitivity Syndrome in an Asian Indian Cohort from a Single Centre in Western India.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2021

The laboratory in the multidisciplinary diagnosis of differences or disorders of sex development (DSD): III) Biochemical and genetic markers in the 46,XYIV) Proposals for the differential diagnosis of DSD.

Advances in laboratory medicine
2021

Characteristics and possible mechanisms of 46, XY differences in sex development caused by novel compound variants in NR5A1 and MAP3K1.

Orphanet journal of rare diseases
2021

A case of late diagnosis and management of 46 XY complete gonadal dysgenesis in adulthood.

Ginekologia polska
2021

Whole exome sequencing and functional characterization increase diagnostic yield in siblings with a 46, XY difference of sexual development (DSD).

The Journal of steroid biochemistry and molecular biology
2021

Advances in genomic diagnosis of a large cohort of Egyptian patients with disorders of sex development.

American journal of medical genetics. Part A
2021

Prophylactic gonadectomy in 46 XY females; why, where and when?

Hormone molecular biology and clinical investigation
2021

Clinical phenotype and management of individuals with mosaic monosomy X with Y chromosome material stratified by genital phenotype.

American journal of medical genetics. Part A
2020

A case report of 46,XY partial gonadal dysgenesis caused by a novel mutation in the sex-determining region gene.

Translational pediatrics
2020

ANDROGEN INSENSITIVITY SYNDROME,REVIEW OF LITERATURE BASED ON CASE REPORTS.

Georgian medical news
2021

Gender identity disorder (GID) in adolescents and adults with differences of sex development (DSD): A systematic review and meta-analysis.

Journal of pediatric urology
2020

Variants of STAR, AMH and ZFPM2/FOG2 May Contribute towards the Broad Phenotype Observed in 46,XY DSD Patients with Heterozygous Variants of NR5A1.

International journal of molecular sciences
2020

XY Gonadal Dysgenesis in a Phenotypic Female Identified by Direct-to-Consumer Genetic Testing.

Pediatrics
2021

Identification of four novel variant in the AMHR2 gene in six unrelated Turkish families.

Journal of endocrinological investigation
2020

Demetylation of the sex-determining region Y gene promoter and incidence of disorder of sex development in cloned dog males.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
2021

Prevalence of gene mutations in a Chinese 46,XY disorders of sex development cohort detected by targeted next-generation sequencing.

Asian journal of andrology
2020

46,XY DSD and limb abnormalities in a female with a de novo LHX9 missense mutation.

American journal of medical genetics. Part A
2021

Molecular genetics of disorders of sex development in a highly consanguineous population.

The Journal of steroid biochemistry and molecular biology
2020

Molecular genetic analysis of AKR1C2-4 and HSD17B6 genes in subjects 46,XY with hypospadias.

Journal of pediatric urology
2020

A non-surgical approach to 46,XY differences in sex development through hormonal suppression at puberty: a single-center case series study.

Endocrine
2020

Genetic Analysis of 25 Patients with 5α-Reductase Deficiency in Chinese Population.

BioMed research international
2020

Monochorionic diamniotic twins of discordant external genitalia with 45,X/46,XY mosaicism.

Molecular genetics &amp; genomic medicine
2020

A Case of 45,X/46,XY Mosaicism Presenting as Swyer Syndrome.

Journal of pediatric and adolescent gynecology
2019

NR5A1 Gene Variants: Variable Phenotypes, New Variants, Different Outcomes.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2020

Clinical, hormonal and genetic characteristics of androgen insensitivity syndrome in 39 Chinese patients.

Reproductive biology and endocrinology : RB&amp;E
2020

Mutational Analysis of the Putative Anti-Müllerian Hormone (AMH) Binding Interface on its Type II Receptor, AMHR2.

Endocrinology
2019

Persistent Müllerian duct syndrome: an update.

Reproduction, fertility, and development
2020

Oligogenic Origin of Differences of Sex Development in Humans.

International journal of molecular sciences
2020

High Molecular Diagnosis Rate in Undermasculinized Males with Differences in Sex Development Using a Stepwise Approach.

Endocrinology
2020

Analysis of variants in GATA4 and FOG2/ZFPM2 demonstrates benign contribution to 46,XY disorders of sex development.

Molecular genetics &amp; genomic medicine
2020

A rare cause of delayed puberty in two cases with 46,XX and 46,XY karyotype: 17 α-hydroxylase deficiency due to a novel variant in CYP17A1 gene.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
2019

Clinical Findings and Follow-Up of 46,XY and 45,X/46,XY Testicular Dysgenesis.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2020

The XY Female: Exploring Care for Adolescent Girls with Complete Androgen Insensitivity Syndrome.

Comprehensive child and adolescent nursing
2019

Disorders Of Sex Differentiation: Evaluation And Management, A Dilemma.

Journal of Ayub Medical College, Abbottabad : JAMC
2020

Mutation update for the NR5A1 gene involved in DSD and infertility.

Human mutation
2019

Sex Assignment and Diagnostics in Infants with Ambiguous Genitalia - A Single-Center Retrospective Study.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2019

Management of 46,XY Differences/Disorders of Sex Development (DSD) Throughout Life.

Endocrine reviews
2019

The importance of the multiplex ligation-dependent probe amplification in the identification of a novel two-exon deletion of the NR5A1 gene in a patient with 46,XY differences of sex development.

Molecular biology reports
2020

Pathogenic variants in the DEAH-box RNA helicase DHX37 are a frequent cause of 46,XY gonadal dysgenesis and 46,XY testicular regression syndrome.

Genetics in medicine : official journal of the American College of Medical Genetics
2019

Genetic Evidence of the Association of DEAH-Box Helicase 37 Defects With 46,XY Gonadal Dysgenesis Spectrum.

The Journal of clinical endocrinology and metabolism
2019

A mutation inactivating the distal SF1 binding site on the human anti-Müllerian hormone promoter causes persistent Müllerian duct syndrome.

Human molecular genetics
2019

[Gender selection and postoperative follow-up analysis in 85 children with 46, XY disorders of sex development].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2019

Serum steroid profiling in Cushing's syndrome patients.

The Journal of steroid biochemistry and molecular biology
2019

New insights into 5α-reductase type 2 deficiency based on a multi-centre study: regional distribution and genotype-phenotype profiling of SRD5A2 in 190 Chinese patients.

Journal of medical genetics
2019

Compound heterozygous mutations in the luteinizing hormone receptor signal peptide causing 46,XY disorder of sex development.

European journal of endocrinology
2019

Voice dissatisfaction in individuals with a disorder of sex development.

Clinical endocrinology
2019

Functional analysis of novel desert hedgehog gene variants improves the clinical interpretation of genomic data and provides a more accurate diagnosis for patients with 46,XY differences of sex development.

Journal of medical genetics
2019

TESTICULAR REGRESSION SYNDROME: PRACTICE VARIATION IN DIAGNOSIS AND MANAGEMENT.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
2019

Establishing reproductive potential and advances in fertility preservation techniques for XY individuals with differences in sex development.

Clinical endocrinology
2019

PPP2R3C gene variants cause syndromic 46,XY gonadal dysgenesis and impaired spermatogenesis in humans.

European journal of endocrinology
2019

[Clinical phenotype and gene analysis of 86 cases of 5 alpha reductase deficiency].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2019

Tri-allelic expression of HLA gene in 46,XX/46,XY chimerism.

Transplant immunology
2018

Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9.

Nature communications
2018

Integrating clinical and genetic approaches in the diagnosis of 46,XY disorders of sex development.

Endocrine connections
2018

Persistent Mullerian duct syndrome: Report of two cases with phenotypical immunohistochemical profiling.

Urologia
2018

[Differences of Sex Development (DSD): Controversies and Challenges].

Annales d'endocrinologie
2018

Sertoli Cell Tumour and Uterine Leiomyoma in Miniature Schnauzer Dogs with Persistent Müllerian Duct Syndrome Caused by Mutation in the AMHR2 Gene.

Journal of comparative pathology
2018

Childhood Sex-Typed Behavior and Gender Change in Individuals with 46,XY and 46,XX Disorders of Sex Development: An Iranian Multicenter Study.

Archives of sexual behavior
2018

Novel homozygous nonsense mutations in LHCGR lead to empty follicle syndrome and 46, XY disorder of sex development.

Human reproduction (Oxford, England)
2018

A Novel Mutation of AMHR2 in Two Siblings with Persistent Müllerian Duct Syndrome.

Journal of clinical research in pediatric endocrinology
2018

Clinical aspects of 49 infertile males with 45,X/46,XY mosaicism karyotype: A case series.

Andrologia
2018

Prenatal testosterone and theory of mind development: Findings from disorders of sex development.

Psychoneuroendocrinology
2017

Phenotypic Variation in 46,XX Disorders of Sex Development due to the NR5A1 p.R92W Variant: A Sibling Case Report and Literature Review.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2018

Identification of novel candidate genes for 46,XY disorders of sex development (DSD) using a C57BL/6J-Y POS mouse model.

Biology of sex differences
2018

Mutations involving the SRY-related gene SOX8 are associated with a spectrum of human reproductive anomalies.

Human molecular genetics
2018

Growth, sexual and bone development in a boy with bilateral anorchia under testosterone treatment guided by the development of his monozygotic twin.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2017

Recurrent Intragenic Duplication within the NR5A1 Gene and Severe Proximal Hypospadias.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2018

Partial androgen insensitivity syndrome due to somatic mosaicism of the androgen receptor.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2017

A Novel Sex Chromosome Mosaicism 45,X/45,Y/46,XY/46,YY/47,XYY Causing Ambiguous Genitalia.

Annals of clinical and laboratory science
2018

Biallelic and monoallelic ESR2 variants associated with 46,XY disorders of sex development.

Genetics in medicine : official journal of the American College of Medical Genetics
2017

Functional Impact of Novel Androgen Receptor Mutations on the Clinical Manifestation of Androgen Insensitivity Syndrome.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2017

Four Novel NR5A1 Mutations in 46,XY Gonadal Dysgenesis Patients Including Frameshift Mutations with Altered Subcellular SF-1 Localization.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2018

Risk association of congenital anomalies in patients with ambiguous genitalia: A 22-year single-center experience.

Journal of pediatric urology
2018

Human Chorionic Gonadotropin Test: Old Uncertainties, New Perspectives, and Value in 46,XY Disorders of Sex Development.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2018

Biallelic mutations in FLNB cause a skeletal dysplasia with 46,XY gonadal dysgenesis by activating β-catenin.

Clinical genetics
2018

Multiparameter Investigation of a 46,XX/46,XY Tetragametic Chimeric Phenotypical Male Patient with Bilateral Scrotal Ovotestes and Ovulatory Activity.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2017

17β-Hydroxysteroid dehydrogenase 3 deficiency: Three case reports and a systematic review.

The Journal of steroid biochemistry and molecular biology
2017

Heterogeneity of human WT1 gene.

Postepy higieny i medycyny doswiadczalnej (Online)
2017

The possible role of AMH in shortening the gubernacular cord in testicular descent: A reappraisal of the evidence.

Journal of pediatric surgery
2017

The Persistent Müllerian Duct Syndrome: An Update Based Upon a Personal Experience of 157 Cases.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2017

Clinical heterogeneity in children with gonadal dysgenesis associated with non-mosaic 46,XY karyotype.

Journal of pediatric urology
2017

Birth Weight in Different Etiologies of Disorders of Sex Development.

The Journal of clinical endocrinology and metabolism
2017

17α-HYDROXYLASE/17, 20-LYASE DEFICIENCY: CLINICAL AND MOLECULAR CHARACTERIZATION OF EIGHT CHINESE PATIENTS.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença do desenvolvimento sexual 46,XY.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença do desenvolvimento sexual 46,XY

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Identification of Novel and Known Variants in Epigenetic Genes Associated with Syndromic 46,XY Differences of Sex Development among Moroccan Patients.
    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation· 2026· PMID 41666144mais citado
  2. Rare phenotypic spectrum of 17&#x3b2;-hydroxysteroid dehydrogenase 3 deficiency: case series from infancy to adolescence.
    Journal of pediatric endocrinology &amp; metabolism : JPEM· 2026· PMID 41580999mais citado
  3. Upstream SOX9 deletion in a 46,XY girl with acampomelic campomelic dysplasia and absent minipuberty.
    Orphanet journal of rare diseases· 2025· PMID 41272840mais citado
  4. Molecular genetic diagnosis and surgical management in a cohort of children with 46,XY disorders/differences of sex development.
    Frontiers in pediatrics· 2025· PMID 39936125mais citado
  5. Functional analysis of SRY variants in individuals with 46,XY differences of sex development.
    Molecular and cellular endocrinology· 2025· PMID 39788310mais citado
  6. Close relationship, similar phenotype of GATA4 and NR5A1 mutations: gonadal dysgenesis and puberty development.
    J Endocrinol Invest· 2025· PMID 41023526recente
  7. Pubertal Development as a Marker of Gonadal Neoplasm in 46XY Complete Gonadal Dysgenesis.
    J Pediatr Adolesc Gynecol· 2025· PMID 40683524recente
  8. Phenotypic Variation and Pubertal Outcomes in Males and Females With 46,XY Partial Gonadal Dysgenesis.
    J Clin Endocrinol Metab· 2025· PMID 40208111recente
  9. [Value of the human chorionic gonadotropin stimulation test in the diagnosis of disorder of sexual development in children].
    Zhongguo Dang Dai Er Ke Za Zhi· 2024· PMID 38436313recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98085(Orphanet)
  2. MONDO:0020040(MONDO)
  3. GARD:8538(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença do desenvolvimento sexual 46,XY
Compêndio · Raras BR

Doença do desenvolvimento sexual 46,XY

ORPHA:98085 · MONDO:0020040
Prevalência
1-9 / 100 000
Prevalência
0.06 (Denmark)
MedGen
UMLS
C2751824
EuropePMC
Wikipedia
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades